A previous clinical trial found that tamoxifen, taken for five years, reduced the risk of developing invasive breast cancer by about 50% in post-menopausal women who were at increased risk of getting the disease.
Another trial found that five years of raloxifene reduces breast cancer risk in such women by about 38%.
Under the new plans, high risk post-menopausal women could be offered the drugs for a period of five years unless they have a history of thromboembolic disease or endometrial cancer.
More top news
A mass inhalation of "hippy crack" was carried out in the shadow of Parliament on Saturday in protest at the Government's drug policy.
Declan Donnelly is reportedly tying the knot with his manager partner Ali Astall in Newcastle today.
Warming up in the south but with breezy showers across Scotland today.